BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7978716)

  • 1. End-stage renal disease attributable to diabetes mellitus.
    Perneger TV; Brancati FL; Whelton PK; Klag MJ
    Ann Intern Med; 1994 Dec; 121(12):912-8. PubMed ID: 7978716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
    Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minority advantage in diabetic end-stage renal disease survival on hemodialysis: due to different proportions of diabetic type?
    Medina RA; Pugh JA; Monterrosa A; Cornell J
    Am J Kidney Dis; 1996 Aug; 28(2):226-34. PubMed ID: 8768918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.
    Humphrey LL; Ballard DJ; Frohnert PP; Chu CP; O'Fallon WM; Palumbo PJ
    Ann Intern Med; 1989 Nov; 111(10):788-96. PubMed ID: 2817626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy.
    Pugh JA; Medina R; Ramirez M
    Diabetologia; 1993 Oct; 36(10):1094-8. PubMed ID: 8243860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of the rate of renal function decline in non-insulin-dependent diabetes mellitus.
    Garza R; Medina R; Basu S; Pugh JA
    Am J Nephrol; 1997; 17(1):59-67. PubMed ID: 9057955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
    Bonomo JA; Ng MC; Palmer ND; Keaton JM; Larsen CP; Hicks PJ; ; Langefeld CD; Freedman BI; Bowden DW
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1434-40. PubMed ID: 24948143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians.
    Nelson RG; Newman JM; Knowler WC; Sievers ML; Kunzelman CL; Pettitt DJ; Moffett CD; Teutsch SM; Bennett PH
    Diabetologia; 1988 Oct; 31(10):730-6. PubMed ID: 3240833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
    Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.
    Bruce R; Williams L; Cundy T
    Aust N Z J Med; 1994 Aug; 24(4):390-5. PubMed ID: 7980236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom.
    Burden AC; McNally PG; Feehally J; Walls J
    Diabet Med; 1992; 9(7):641-5. PubMed ID: 1511571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.
    Crook ED; Patel S
    Ethn Dis; 2006; 16(4):865-71. PubMed ID: 17061739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial variation in human leukocyte antigen frequency in insulin-dependent diabetic nephropathy. The South-Eastern Organ Procurement Foundation.
    Freedman BI; Espeland MA; Heise ER; Evans J; Canzanello VJ
    J Am Soc Nephrol; 1993 Feb; 3(8):1467-73. PubMed ID: 8490118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with the development of renal complications of diabetes mellitus in São Paulo city.
    Ferreira SR; Pinto FM
    Braz J Med Biol Res; 1997 Jun; 30(6):735-44. PubMed ID: 9292110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.